REUTERS

ACLU Slams Trump for Plans to End Birthright Citizenship

President Trump said that he plans to sign an executive order to end birthright citizenship to children born in the United States to non-citizens and undocumented immigrants. The American Civil Liberties Union (ACLU) said it’s an attempt to “fan the flames of anti-immigrant hatred” before next week’s midterm elections.


Axois released a clip of an interview with Trump set to air on HBO on Sunday where he talks about an executive order.

“It was always told to me you needed a Constitutional amendment,” Trump says. “Guess what You don’t.”

One of the hosts replies, “That’s in dispute.”

Trump answered, “You can definitely do it with an act of Congress, but now they’re saying I can do it with just an executive order. We’re the only country in the world where a person comes in, has a baby and the baby is essentially a citizen of the United States for 85 years with all of those benefits. It’s ridiculous. And it has to end.”

Trump is incorrect.

The U.S. isn’t the only country in the world that offers birthright citizenship there are more than 20 other countries, including Canada:

Antigua and Barbuda; Canada; Argentina; Barbados; Belize; Bolivia; Brazil; Canada; Chile; Cuba; Dominican Republic; Ecuador; El Salvador; Fiji; Grenada; Guatemala; Guyana; Honduras; Jamaica; Mexico; Nicaragua; Panama; Paraguay; Peru; St. Kitts and Nevis; St. Lucia; St. Vincent and the Grenadines; Trinidad and Tobago; United States; Uruguay; and Venezuela.

Trump said he’s talked with counsel about issuing the executive order.

“It’s in the process; it will happen,” he said.

The 14th Amendment states, “All persons born or naturalized in the United States, and subject to the jurisdiction thereof, are citizens of the United States and of the State wherein they reside.”

In order to change an amendment in the Constitution, it would require the support of two-thirds of the Senate and House of Representatives and must be approved by three-fourths of state legislatures at a constitutional convention.

Trump’s executive order takes direct aim at the Constitution. It would be one of the most sweeping moves of his administration and would likely be opposed in Congress. He would face legal challenge, prompting the nation’s courts to weigh in.

“This is a blatantly unconstitutional attempt to fan the flames of anti-immigrant hatred in the days ahead of the midterms,” the ACLU said, in a statement, on Twitter.

“The 14th Amendment’s citizenship guarantee is clear. You can’t erase the Constitution with an executive order, @realDonaldTrump.”

Trump has referred to thousands migrants traveling to the U.S. to flee violence in Central America as an “invasion.” And his attempt to challenge the 14th Amendment falls in line with usual pandering to his base.

As a presidential candidate, he called for an end to birthright citizenship, calling it in one of his first policy papers the “biggest magnet for illegal immigration.”

View a clip of the Axios interview:


Trump immigration executive order: President to terminate birthright citizenship

youtu.be

Latest News

What Friends Tell Friends: Choose Kaiser Permanente

Originally published on about.kaiserpermanente.org. Integrated, nonprofit health plan tops NICE Satmetrix customer experience benchmark study for 10th straight year. For the 10th year in a row, more people would recommend Kaiser Permanente to a friend or colleague than any other health plan in the nation, according to the recently released…

Cesar Conde

NBCUniversal Sets Ambitious 50% Diversity Goal for Women, People of Color

Cesar Conde, chairman at NBCUniversal News Group, announced a groundbreaking goal to have a 50% diverse workforce at NBCUniversal, according to Deadline. Conde, the first Latino in this role, outlined his plans in an internal video for employees on Wednesday. The ultimate goal is for NBCUniversal, No. 7 on DiversityInc’s 2020…

Mastercard Expands ShopOpenings.com to the U.S. & Canada, Delivering a Search Tool That Identifies What Stores Near You Are Open for Business

Originally published on mastercardcontentexchange.com. Search solution complements new Digital Acceleration for Small Business global initiative which helps small businesses advance digitally and drive online commerce As businesses seek to draw customers back both in store and online, Mastercard is introducing new tools to support them. Today, Mastercard announced the geographic…

TIAA Launches Programs to Raise Awareness of Racial Injustice and Support Communities in Need through the “Be The Change” Initiative

On June 30, TIAA announced new virtual programs designed to raise awareness of racial injustice and support communities in need as a part of the company’s recently launched “Be the Change” initiative. One is TIAA’s “Race Against Racism,” an effort in support of The Innocence Project which included more than…

Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries

Originally published on jnj.com. Joint efforts aim to accelerate scale-up of WHO-recommended all-oral treatment regimens – a transition urgently needed to help protect the health of people with drug resistant-tuberculosis who are particularly vulnerable during COVID-19 pandemic In 2020, the initiative aims to reach at least 125,000 patients and could…

Toyota, Alabama A&M and Huntsville Hospital Collaborate to Make COVID-19 Testing Easier

Originally published on pressroom.toyota.com. $100,000 grant provides free service to the community Alabama A & M University (AAMU), Huntsville Hospital and Toyota are developing a mobile health clinic initiative to provide free COVID-19 testing to underserved communities in Madison County. Launching later this year, the mobile medical clinic program has…

Sanofi and Regeneron Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients

Originally published on sanofi.com. Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Phase 3 trial of Kevzara® (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints when Kevzara was added to best supportive care compared to best supportive care alone (placebo)….